The IRE1α-XBP1s pathway promotes insulin-stimulated glucose uptake in adipocytes by increasing PPARγ activity

Diabetes: Restoring insulin sensitivity Researchers have identified a protein, XBP1s, that may help treat type II diabetes by re-sensitizing cells to insulin. Insulin controls blood sugar levels by triggering cells to absorb sugar from the blood. In obese individuals, cells can lose sensitivity to i...

Full description

Bibliographic Details
Main Authors: Yoon Mi Cho, Dong Hee Kim, Kyung Hye Lee, Seong-Whan Jeong, Oh-Joo Kwon
Format: Article
Language:English
Published: Nature Publishing Group 2018-08-01
Series:Experimental and Molecular Medicine
Online Access:https://doi.org/10.1038/s12276-018-0131-0
id doaj-92a17dfab8134e1aa54f1373a46c021b
record_format Article
spelling doaj-92a17dfab8134e1aa54f1373a46c021b2020-12-08T13:52:10ZengNature Publishing GroupExperimental and Molecular Medicine2092-64132018-08-0150811510.1038/s12276-018-0131-0The IRE1α-XBP1s pathway promotes insulin-stimulated glucose uptake in adipocytes by increasing PPARγ activityYoon Mi Cho0Dong Hee Kim1Kyung Hye Lee2Seong-Whan Jeong3Oh-Joo Kwon4Department of Biochemistry, College of Medicine, The Catholic University of KoreaDepartment of Biochemistry, College of Medicine, The Catholic University of KoreaDepartment of Biochemistry, College of Medicine, The Catholic University of KoreaDepartment of Biochemistry, College of Medicine, The Catholic University of KoreaDepartment of Biochemistry, College of Medicine, The Catholic University of KoreaDiabetes: Restoring insulin sensitivity Researchers have identified a protein, XBP1s, that may help treat type II diabetes by re-sensitizing cells to insulin. Insulin controls blood sugar levels by triggering cells to absorb sugar from the blood. In obese individuals, cells can lose sensitivity to insulin, requiring increasing quantities to trigger sugar uptake, disrupting blood sugar regulation. Termed insulin resistance, this is a major risk factor for type II diabetes and other diseases. XBP1s was previously known to affect insulin sensitivity, but the mechanism was unclear. Oh-Joo Kwon and co-workers at The Catholic University of Korea in Seoul investigated how XBP1s affected the response of mouse fat cells to insulin. They found that XBP1s restored insulin sensitivity, turning insulin-resistant cells into cells that responded to insulin by absorbing sugar. XBP1s may be useful in treatment or prevention of type II diabetes.https://doi.org/10.1038/s12276-018-0131-0
collection DOAJ
language English
format Article
sources DOAJ
author Yoon Mi Cho
Dong Hee Kim
Kyung Hye Lee
Seong-Whan Jeong
Oh-Joo Kwon
spellingShingle Yoon Mi Cho
Dong Hee Kim
Kyung Hye Lee
Seong-Whan Jeong
Oh-Joo Kwon
The IRE1α-XBP1s pathway promotes insulin-stimulated glucose uptake in adipocytes by increasing PPARγ activity
Experimental and Molecular Medicine
author_facet Yoon Mi Cho
Dong Hee Kim
Kyung Hye Lee
Seong-Whan Jeong
Oh-Joo Kwon
author_sort Yoon Mi Cho
title The IRE1α-XBP1s pathway promotes insulin-stimulated glucose uptake in adipocytes by increasing PPARγ activity
title_short The IRE1α-XBP1s pathway promotes insulin-stimulated glucose uptake in adipocytes by increasing PPARγ activity
title_full The IRE1α-XBP1s pathway promotes insulin-stimulated glucose uptake in adipocytes by increasing PPARγ activity
title_fullStr The IRE1α-XBP1s pathway promotes insulin-stimulated glucose uptake in adipocytes by increasing PPARγ activity
title_full_unstemmed The IRE1α-XBP1s pathway promotes insulin-stimulated glucose uptake in adipocytes by increasing PPARγ activity
title_sort ire1α-xbp1s pathway promotes insulin-stimulated glucose uptake in adipocytes by increasing pparγ activity
publisher Nature Publishing Group
series Experimental and Molecular Medicine
issn 2092-6413
publishDate 2018-08-01
description Diabetes: Restoring insulin sensitivity Researchers have identified a protein, XBP1s, that may help treat type II diabetes by re-sensitizing cells to insulin. Insulin controls blood sugar levels by triggering cells to absorb sugar from the blood. In obese individuals, cells can lose sensitivity to insulin, requiring increasing quantities to trigger sugar uptake, disrupting blood sugar regulation. Termed insulin resistance, this is a major risk factor for type II diabetes and other diseases. XBP1s was previously known to affect insulin sensitivity, but the mechanism was unclear. Oh-Joo Kwon and co-workers at The Catholic University of Korea in Seoul investigated how XBP1s affected the response of mouse fat cells to insulin. They found that XBP1s restored insulin sensitivity, turning insulin-resistant cells into cells that responded to insulin by absorbing sugar. XBP1s may be useful in treatment or prevention of type II diabetes.
url https://doi.org/10.1038/s12276-018-0131-0
work_keys_str_mv AT yoonmicho theire1axbp1spathwaypromotesinsulinstimulatedglucoseuptakeinadipocytesbyincreasingppargactivity
AT dongheekim theire1axbp1spathwaypromotesinsulinstimulatedglucoseuptakeinadipocytesbyincreasingppargactivity
AT kyunghyelee theire1axbp1spathwaypromotesinsulinstimulatedglucoseuptakeinadipocytesbyincreasingppargactivity
AT seongwhanjeong theire1axbp1spathwaypromotesinsulinstimulatedglucoseuptakeinadipocytesbyincreasingppargactivity
AT ohjookwon theire1axbp1spathwaypromotesinsulinstimulatedglucoseuptakeinadipocytesbyincreasingppargactivity
AT yoonmicho ire1axbp1spathwaypromotesinsulinstimulatedglucoseuptakeinadipocytesbyincreasingppargactivity
AT dongheekim ire1axbp1spathwaypromotesinsulinstimulatedglucoseuptakeinadipocytesbyincreasingppargactivity
AT kyunghyelee ire1axbp1spathwaypromotesinsulinstimulatedglucoseuptakeinadipocytesbyincreasingppargactivity
AT seongwhanjeong ire1axbp1spathwaypromotesinsulinstimulatedglucoseuptakeinadipocytesbyincreasingppargactivity
AT ohjookwon ire1axbp1spathwaypromotesinsulinstimulatedglucoseuptakeinadipocytesbyincreasingppargactivity
_version_ 1724389149142679552